Positive and negative regulation of the Fcγ receptor–stimulating activity of RNA-containing immune complexes by RNase

RNase treatment, which degrades RNA in ICs [Immune Complexes], has been tested in clinical trials as a potential therapeutic agent.

10.1172/jci.insight.167799